IPA PARTICIPATION IN 58TH WORLD HEALTH ASSEMBLY
GENEVA, MAY 16-25, 2005

← Back to newsletter

May 30, 2005

IPA was represented at the 58th World Health Assembly by President Adenike Grange, President-elect Chok-wan Chan, Treasurer Sergio Cabral, Coordinator Sverre Lie, and Executive Director, Jane Schaller

The meeting, which is essentially a mini-United Nations for Health, was attended by delegations from 192 listed Member States, 5 observer states and 3 observer organizations, 33 United Nations or related international agencies, 15 intergovernmental organizations, and 132 non-governmental organizations.

A briefing for non-governmental organizations on the first day covered topics including disability, harmful use of alcohol, anti-microbial resistance, the draft global immunization strategy, and social health insurance.

The World Health Assembly itself opened with a plenary session which conducted business including elections, nominations, adoption of the agenda, and reports from the Executive Board of its two sessions during the last year.

Plenary addresses were given by Dr. Lee, Director General of WHO, Mr. Maumoon Abdul Gayoom, President of the Republic of Maldives, and Bill Gates of the Gates Foundation.

The main business of the Assembly was then conducted in Committees A and B.

Committee A considered program budgets and a number of so-called technical and health matters which included:

Committee B considered predominately business matters:

This was an extremely full agenda: Reports and documents of the World Health Assembly are available on the WHO web site (www.who.org).

Most of the items discussed were of interest to IPA. IPA had three intervention statements accepted and they are attached to this report:

Several discussion items were of particular interest to IPA:

The World Health Assembly was adjourned on Wednesday the 25th of May.

Recommendations for IPA:

  1. It is valuable to have official IPA representation at the World Health Assembly. This provides an invaluable opportunity to meet Ministers of Health, funders, and major players in global health.

  2. IPA should try to have a designated representative at all of the upcoming regional WHO meetings. The regional meetings are:
    • Africa: Mozambique, 22-26 August
    • Southeast Asia: Sri Lanka 6-10 September
    • Europe: Bucharest 12-15 September
    • Western Pacific: Noumea, 19-23 September
    • Eastern Mediterranean: Cairo 24-27 September
    • The Americas (PAHO), Washington, D.C. 26-30 September

  3. Some funding for representation of IPA at WHO meetings should be discussed.

  4. IPA representatives officially attending any WHO meeting must be well briefed and prepared to emphasize IPA policies and interests.

  5. IPA is working with both Child and Adolescent Health and with Health Action in Crisis to forge formal working structures. Stay tuned.

Jane Schaller
Executive Director